Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:1279-1280 (23 December), doi:10.1136/bmj.39048.428380.80
A medical prize fund could improve the financing of drug innovations
| The first 150 words of the full text of this article appear below. |
At Christmas, we traditionally retell Dickens's story of Scrooge, who cared more for money than for his fellow human beings. What would we think of a Scrooge who could cure diseases that blighted thousands of people's lives but did not do so? Clearly, we would be horrified. But this has increasingly been happening in the name of economics, under the innocent sounding guise of "intellectual property rights."
Intellectual property differs from other propertyrestricting its use is inefficient as it costs nothing for another person to use it. Thomas Jefferson, America's third president, put it more poetically than modern economists (who refer to "zero marginal costs" and "non-rivalrous consumption") when he said that knowledge is like a candle, when one candle lights another it does not diminish from the light of the first. Using knowledge to help someone does not prevent that knowledge from helping others. Intellectual property rights, however, enable
Joseph E Stiglitz, professor
1 Columbia University, New York, NY 10025, USA
jb2632@columbia.edu
Read all Rapid Responses
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care